Positive clinical outcomes of cryopreserved human placenta membrane in treatment of diabetic foot ulcers
Diabetes is the inability of our body to produce or use insulin. Insulin is a hormone which allows your body to turn sugars and glucose to energy. So if a body has difficulty in metabolizing glucose and sugar there will be decrease in energy production, prevent oxygen and nutrients from energizing cells, prevent immune system from functioning properly and hence delay wound healing and ulcers. There are many other factors that contribute to delayed healing in such individuals like decreased or impaired growth factor (GF) production, angiogenic response , macrophage function, collagen accumulation and quantity of granulation tissue
Other
The placenta has biological properties that are beneficial to the wound healing process of diabetic foot ulcers (DFU) . It contains mesenchymal stems cells (MSCs). MSCs are ‘multipotent’, meaning they can produce several types of specialized cells, such as cartilage, bone, and fat cells that can repair damage from illness or injury. The aim of this report is to analyze the scientific evidence found in literature on the use of the placenta membrane to stimulate DFU healing
